Research Groups and R&D Platforms: Ageing-related diseases
Research Group:
Cardiac Biomarkers
Saara Wittfooth
saara.wittfooth@utu.fi
Department of Life Technologies,
University of Turku
Ageing-related diseases, Antibodies, Assay development, Autoimmune diseases, Biomarker, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, In Vitro Diagnostics, Inflammation, Metabolic diseases, Obesity
Research Group:
Kinase Function in Brain
Eleanor Coffey
eleanor.coffey[at]bioscience.fi
Turku Bioscience Centre,
Åbo Akademi University and University of Turku
Ageing-related diseases, Basic research, Biomarker, Biomedicine, Data mining, Diagnostics, Disease models, Drug delivery, Drug target, In Vitro Diagnostics, In Vivo Diagnostics, Molecular Biology, Molecular diagnostics, Molecular modelling, Neurological disorders, PET, Proteomics, Screening, Signaling, Super-resolution imaging, Systems Biology, Target discovery
Research Group:
New tools to target harmful inflammations and cancer
Sirpa Jalkanen
sirjal[at]utu.fi
Institute of Biomedicine,
University of Turku
Cell Trafficking in Cancer and Inflammation
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery
Research Group:
Biomedical Epigenomics
Riikka Lund
riikka.lund[at]utu.fi
Biomedical Epigenomics Group,
Turku Bioscience Centre,
University of Turku
Ageing-related diseases, Basic research, Biomarker, Biomedicine, Biotechnology, Data mining, Diagnostics, Disease models, Drug target, Epigenomics, Genetics, Genomics, Imaging, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Target discovery
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Radiochemistry for development of radiotracers for Positron Emission Tomography
Olof Solin
olof.solin[at]abo.fi, olof.solin[at]utu.fi
Turku PET Centre and Department of Chemistry,
University of Turku
Ageing-related diseases, Autoimmune diseases, Biomarker, Cancer, Data mining, Diabetes, Disease models, Drug delivery, Drug stability, Drug target, Formulation, Imaging, Imaging software, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular diagnostics, Molecular modelling, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Obesity, Organic compounds, Particle size analysis, PET, Physico-chemical properties, Receptor, Signaling, Synthetic chemistry, Target discovery, Zeta potential
